Professional Documents
Culture Documents
Trigger
• 60 y/o woman, present with depressed mood after her son passed away. The patient report a 10kg
weight loss, decrease concentration, feeling helplessness & hopelessness, decrease energy & sleep
Definition
• Mood disorder, that present with at least 2 weeks of course of symptoms that change from patient
previous functional level. Must have depressed mood or anhedonia (inability to enjoy oneself)
Most common
• Age group : 20 – 40 y/o
• Gender : Female 2X – because hormonal differences, great stress
History
• Depressed mood – most of the day
• Anhedonia – most of the day
• Significant weight loss (>5% of body weight)
• Insomnia
• Psychomotor agitation or retardation
• Low energy
• Low concentration
• Feeling of worthlessness or guilt
• Recurrent thoughts about death
Most important thing to assess in patients suffering from depression is their suicidal status, which of
course determines her prognosis and whether or not you will admit her to the hospital for treatment
Physical examination
• Psychomotor retardation – stooped posture, slow movement, slow speech
• Cognitive impairment - concentration & memory
Incidence
• Risk of developing MDD in life time : 15%
• Risk of MDD causing Suicide : 15%
Triggering factor
• Drug : Beta blocker, Corticosteroid, Benzodiazepine, Interferon
• Endocrine : Hypothyroid (T3/T4), Adrenal dysfunction ( Noradrenaline)
• Neurologic : Parkinson, Strokes, Dementia
• Metabolic disorder : Vitamin B12 deficiency
• Infection : HIV, Hepatitis – Stigma
Risk factor
• Chronic physical illness
• Substance : Alcohol or drug dependence
• Psychosocial stressor *
• Gender : Female
• Childbirth
• Family history of depression
• Previous depressive episodes
Diagnosis (DSM 4)
Differential diagnosis
• Medical condition – Hypothyroidism, Parkinson’s diseas, Hypertension
• Substance induced
• Mood disorder
• Dysthymic disorder
• Bipolar disorder
• Dementia
• Schizoaffective disorder
Treatment
Drug
• Continue anti-depressant for 9-12 months before tapered dose initiated
• During tapered phase, monitor for sign of relapse
Class Drug
Selective serotonin reuptake inhibitor (SSRI)
Selective noradrenaline reuptake inhibitor (SNRI)
Dopamine reuptake inhibitor (DRI)
Tricyclic antidepressant (TCA)
Monoamine oxidase inhibitor (MAOI)
Individual psychotherapy
• To help patient deal with conflict, sense of loss
Cognitive therapy
• To change patient distorted thoughts about self, future